• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TEAD4与KLF5之间的相互作用部分通过抑制p27Kip1的转录来促进乳腺癌。

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.

作者信息

Wang Chunyan, Nie Zhi, Zhou Zhongmei, Zhang Hailin, Liu Rong, Wu Jing, Qin Junying, Ma Yun, Chen Liang, Li Shumo, Chen Wenlin, Li Fubing, Shi Peiguo, Wu Yingying, Shen Jian, Chen Ceshi

机构信息

Key Laboratory of Animal Models and Human Disease Mechanisms of The Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.

University of The Chinese Academy of Sciences, Beijing, China.

出版信息

Oncotarget. 2015 Jul 10;6(19):17685-97. doi: 10.18632/oncotarget.3779.

DOI:10.18632/oncotarget.3779
PMID:25970772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4627338/
Abstract

Growing evidence suggests that YAP/TAZ are mediators of the Hippo pathway and promote breast cancer. However, the roles of YAP/TAZ transcription factor partners TEADs in breast cancer remain unclear. Here we found that TEAD4 was expressed in breast cancer cell lines, especially in triple negative breast cancers (TNBC) cell lines. TEAD4 binds to KLF5. Knockdown of either TEAD4 or KLF5 in HCC1937 and HCC1806 cells induced the expression of CDK inhibitor p27. Depletion of either TEAD4 or KLF5 activated the p27 gene promoter and increased the p27 mRNA levels. Depletion of p27 partially prevents growth inhibition caused by TEAD4 and KLF5 knockdown. TEAD4 overexpression stimulated proliferation in vitro and tumor growth in mice, while stable knockdown of TEAD4 inhibited proliferation in vitro and tumor growth in mice. Thus TEAD4 and KLF5, in collaboration, promoted TNBC cell proliferation and tumor growth in part by inhibiting p27 gene transcription. TEAD4 is a potential target and biomarker for the development of novel therapeutics for breast cancer.

摘要

越来越多的证据表明,YAP/TAZ是Hippo信号通路的介质,并促进乳腺癌的发生。然而,YAP/TAZ转录因子伴侣TEADs在乳腺癌中的作用仍不清楚。在这里,我们发现TEAD4在乳腺癌细胞系中表达,尤其是在三阴性乳腺癌(TNBC)细胞系中。TEAD4与KLF5结合。在HCC1937和HCC1806细胞中敲低TEAD4或KLF5会诱导细胞周期蛋白依赖性激酶(CDK)抑制剂p27的表达。敲除TEAD4或KLF5会激活p27基因启动子并增加p27 mRNA水平。敲除p27可部分阻止由TEAD4和KLF5敲低引起的生长抑制。过表达TEAD4会刺激体外细胞增殖和小鼠体内肿瘤生长,而稳定敲低TEAD4则会抑制体外细胞增殖和小鼠体内肿瘤生长。因此,TEAD4和KLF5协同作用,部分通过抑制p27基因转录来促进TNBC细胞增殖和肿瘤生长。TEAD4是开发新型乳腺癌治疗药物的潜在靶点和生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/cc2b8930deef/oncotarget-06-17685-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/9bebe4dbd9ed/oncotarget-06-17685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/a628953eb5a6/oncotarget-06-17685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/0a9de31f3858/oncotarget-06-17685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/c2fa492ad26e/oncotarget-06-17685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/f8e6d5e8c470/oncotarget-06-17685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/cc2b8930deef/oncotarget-06-17685-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/9bebe4dbd9ed/oncotarget-06-17685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/a628953eb5a6/oncotarget-06-17685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/0a9de31f3858/oncotarget-06-17685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/c2fa492ad26e/oncotarget-06-17685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/f8e6d5e8c470/oncotarget-06-17685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e0/4627338/cc2b8930deef/oncotarget-06-17685-g006.jpg

相似文献

1
The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.TEAD4与KLF5之间的相互作用部分通过抑制p27Kip1的转录来促进乳腺癌。
Oncotarget. 2015 Jul 10;6(19):17685-97. doi: 10.18632/oncotarget.3779.
2
Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.Kruppel 样因子 5 转录因子促进乳腺癌中微粒体前列腺素 E2 合酶 1 基因的转录。
J Biol Chem. 2013 Sep 13;288(37):26731-40. doi: 10.1074/jbc.M113.483958. Epub 2013 Aug 2.
3
TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.TEAD4与YAP的相互作用通过控制细胞在G1期的周期停滞来调节肿瘤生长。
Biochem Biophys Res Commun. 2017 Apr 29;486(2):385-390. doi: 10.1016/j.bbrc.2017.03.050. Epub 2017 Mar 14.
4
YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.YAP 通过稳定 KLF5 转录因子部分促进乳腺细胞的增殖和存活。
Am J Pathol. 2012 Jun;180(6):2452-61. doi: 10.1016/j.ajpath.2012.02.025.
5
Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.Krüppel样因子5部分通过上调成纤维细胞生长因子结合蛋白1的转录来促进乳腺细胞增殖。
Oncogene. 2009 Oct 22;28(42):3702-13. doi: 10.1038/onc.2009.235. Epub 2009 Aug 10.
6
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.二甲双胍通过 AMPKα 靶向 YAP1-TEAD4 复合物来调节膀胱癌细胞中的 CCNE1/2。
J Exp Clin Cancer Res. 2019 Aug 27;38(1):376. doi: 10.1186/s13046-019-1346-1.
7
DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling.DANCR 通过 KLF5/p27 信号诱导三阴性乳腺癌的顺铂耐药性。
Am J Pathol. 2023 Mar;193(3):248-258. doi: 10.1016/j.ajpath.2022.11.007. Epub 2022 Dec 10.
8
miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.微小RNA-217通过靶向 Kruppel样因子5抑制三阴性乳腺癌细胞的生长、迁移和侵袭。
PLoS One. 2017 Apr 24;12(4):e0176395. doi: 10.1371/journal.pone.0176395. eCollection 2017.
9
TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.TAZ 拮抗 WWP1 介导的 KLF5 降解,促进乳腺细胞增殖和肿瘤发生。
Carcinogenesis. 2012 Jan;33(1):59-67. doi: 10.1093/carcin/bgr242. Epub 2011 Oct 31.
10
DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.Hippo信号通路转录因子TEAD4的DNA结合机制
Oncogene. 2017 Jul 27;36(30):4362-4369. doi: 10.1038/onc.2017.24. Epub 2017 Apr 3.

引用本文的文献

1
Role of KLF5 in enhancing ovarian cancer stemness and PARPi resistance: mechanisms and therapeutic targeting.KLF5在增强卵巢癌干性和PARP抑制剂耐药性中的作用:机制与治疗靶点
J Transl Med. 2025 Apr 30;23(1):492. doi: 10.1186/s12967-025-06502-6.
2
Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer.KLF5与XPO1之间的正反馈调节促进基底样乳腺癌的细胞周期进程。
Adv Sci (Weinh). 2025 Apr;12(16):e2412096. doi: 10.1002/advs.202412096. Epub 2025 Jan 30.
3
TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma.

本文引用的文献

1
Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells.肿瘤抑制性长链非编码RNA,MT1DP在肝癌细胞中受到YAP和Runx2的负调控,从而抑制叉头框蛋白A1(FoxA1)。
Cell Signal. 2014 Dec;26(12):2961-8. doi: 10.1016/j.cellsig.2014.09.011. Epub 2014 Sep 28.
2
Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.姜黄素通过下调膀胱癌细胞中的YAP/TAZ促进KLF5蛋白酶体降解。
Int J Mol Sci. 2014 Aug 28;15(9):15173-87. doi: 10.3390/ijms150915173.
3
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
TEAD 转录因子家族成为口腔鳞状细胞癌有前途的治疗靶点。
Front Immunol. 2024 Oct 4;15:1480701. doi: 10.3389/fimmu.2024.1480701. eCollection 2024.
4
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression.BRD4 特异性 PROTAC 通过下调 KLF5 表达部分抑制基底样乳腺癌。
Oncogene. 2024 Sep;43(39):2914-2926. doi: 10.1038/s41388-024-03121-1. Epub 2024 Aug 20.
5
Discovery of an independent poor-prognosis subtype associated with tertiary lymphoid structures in breast cancer.在乳腺癌中发现与三级淋巴结构相关的独立不良预后亚型。
Front Immunol. 2024 Mar 20;15:1364506. doi: 10.3389/fimmu.2024.1364506. eCollection 2024.
6
Abrogation of KLF5 sensitizes -proficient pancreatic cancer to PARP inhibition.KLF5的缺失使同源重组 proficient的胰腺癌对PARP抑制敏感。
Acta Biochim Biophys Sin (Shanghai). 2024 Apr 25;56(4):576-585. doi: 10.3724/abbs.2023288.
7
Neutrophil extracellular traps mediate TLR9/Merlin axis to resist ferroptosis and promote triple negative breast cancer progression.中性粒细胞胞外诱捕网通过 TLR9/Merlin 轴抵抗铁死亡并促进三阴性乳腺癌进展。
Apoptosis. 2023 Oct;28(9-10):1484-1495. doi: 10.1007/s10495-023-01866-w. Epub 2023 Jun 27.
8
Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer.靶向 KLF5-EphA2 轴可以抑制基底样乳腺癌的肿瘤干性并克服化疗耐药性。
Int J Biol Sci. 2023 Mar 21;19(6):1861-1874. doi: 10.7150/ijbs.82567. eCollection 2023.
9
Kruppel-like Factors in Skeletal Physiology and Pathologies.Kruppel 样因子在骨骼生理学和病理学中的作用
Int J Mol Sci. 2022 Dec 2;23(23):15174. doi: 10.3390/ijms232315174.
10
Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.原发性人浸润性小叶癌和导管癌中的染色质可及性图谱和活性转录因子。
Breast Cancer Res. 2022 Jul 29;24(1):54. doi: 10.1186/s13058-022-01550-y.
接触抑制和高细胞密度会使哺乳动物雷帕霉素靶蛋白通路失活,从而抑制衰老程序。
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8832-7. doi: 10.1073/pnas.1405723111. Epub 2014 Jun 2.
4
The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.转录调节因子 TAZ 和 YAP 指导转化生长因子 β 诱导的乳腺癌细胞中的肿瘤发生表型。
J Biol Chem. 2014 May 9;289(19):13461-74. doi: 10.1074/jbc.M113.529115. Epub 2014 Mar 19.
5
The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.河马信号转导分子TAZ与SWI/SNF复合物相互作用,以调控乳腺上皮细胞谱系定向分化。
Cell Rep. 2014 Mar 27;6(6):1059-1072. doi: 10.1016/j.celrep.2014.02.038. Epub 2014 Mar 6.
6
[Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP].[Hippo信号通路效应因子TAZ/YAP对间充质干细胞分化的调控]
Yi Chuan. 2013 Nov;35(11):1283-90. doi: 10.3724/sp.j.1005.2013.01283.
7
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.TAZ 是乳腺癌干细胞转移活性和化疗耐药所必需的。
Oncogene. 2015 Feb 5;34(6):681-90. doi: 10.1038/onc.2014.5. Epub 2014 Feb 17.
8
The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.Yes 相关蛋白的 PDZ 结合基序对于其与 TEAD 介导的 CTGF 转录和致癌细胞转化活性的共激活作用是必需的。
Biochem Biophys Res Commun. 2014 Jan 17;443(3):917-23. doi: 10.1016/j.bbrc.2013.12.100. Epub 2013 Dec 28.
9
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.甲羟戊酸途径和 Hippo 途径的相互作用通过 YAP 调节 RHAMM 转录,从而调节乳腺癌细胞的迁移。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E89-98. doi: 10.1073/pnas.1319190110. Epub 2013 Dec 23.
10
Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.整合素连接激酶使 Hippo 肿瘤抑制途径失活。
Nat Commun. 2013;4:2976. doi: 10.1038/ncomms3976.